141 related articles for article (PubMed ID: 20930169)
1. The I{kappa}B kinase inhibitor nuclear factor-{kappa}B essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation.
Grassia G; Maddaluno M; Musilli C; De Stefano D; Carnuccio R; Di Lauro MV; Parratt CA; Kennedy S; Di Meglio P; Ianaro A; Maffia P; Parenti A; Ialenti A
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2458-66. PubMed ID: 20930169
[TBL] [Abstract][Full Text] [Related]
2. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9.
Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691
[TBL] [Abstract][Full Text] [Related]
3. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCα-mediated MKP-1 induction.
Kim SY; Kwon YW; Jung IL; Sung JH; Park SG
Cardiovasc Res; 2011 Nov; 92(2):307-16. PubMed ID: 21840882
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair.
Bu DX; Johansson ME; Ren J; Xu DW; Johnson FB; Edfeldt K; Yan ZQ
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2604-10. PubMed ID: 20864668
[TBL] [Abstract][Full Text] [Related]
5. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation.
Furgeson SB; Simpson PA; Park I; Vanputten V; Horita H; Kontos CD; Nemenoff RA; Weiser-Evans MC
Cardiovasc Res; 2010 May; 86(2):274-82. PubMed ID: 20051384
[TBL] [Abstract][Full Text] [Related]
8. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
9. Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation.
Tas SW; Vervoordeldonk MJ; Hajji N; May MJ; Ghosh S; Tak PP
Arthritis Res Ther; 2006; 8(4):R86. PubMed ID: 16684367
[TBL] [Abstract][Full Text] [Related]
10. The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice.
Grassia G; Maddaluno M; Guglielmotti A; Mangano G; Biondi G; Maffia P; Ialenti A
Cardiovasc Res; 2009 Dec; 84(3):485-93. PubMed ID: 19592568
[TBL] [Abstract][Full Text] [Related]
11. Involvement of c-Jun NH2 terminal kinase and p38MAPK in rapamycin-mediated inhibition of neointimal formation in rat carotid arteries.
Omura T; Yoshiyama M; Izumi Y; Kim S; Matsumoto R; Enomoto S; Kusuyama T; Nishiya D; Nakamura Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
J Cardiovasc Pharmacol; 2005 Oct; 46(4):519-25. PubMed ID: 16160607
[TBL] [Abstract][Full Text] [Related]
12. Acetylbritannilactone Inhibits Neointimal Hyperplasia after Balloon Injury of Rat Artery by Suppressing Nuclear Factor-{kappa}B Activation.
Liu B; Han M; Wen JK
J Pharmacol Exp Ther; 2008 Jan; 324(1):292-8. PubMed ID: 17911374
[TBL] [Abstract][Full Text] [Related]
13. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.
Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK
Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058
[TBL] [Abstract][Full Text] [Related]
14. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress.
Xu C; Chen J; Zhang J; Hu X; Zhou X; Lu Z; Jiang H
Biol Pharm Bull; 2013; 36(10):1549-55. PubMed ID: 23912743
[TBL] [Abstract][Full Text] [Related]
15. A novel antioxidant 3,7-dihydroxy-isoflav-3-ene (DHIF) inhibits neointimal hyperplasia after vessel injury attenuating reactive oxygen species and nuclear factor-kappaB signaling.
Kanellakis P; Pomilio G; Walker C; Husband A; Huang JL; Nestel P; Agrotis A; Bobik A
Atherosclerosis; 2009 May; 204(1):66-72. PubMed ID: 18930230
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen-rich saline prevents neointima formation after carotid balloon injury by suppressing ROS and the TNF-α/NF-κB pathway.
Qin ZX; Yu P; Qian DH; Song MB; Tan H; Yu Y; Li W; Wang H; Liu J; Wang Q; Sun XJ; Jiang H; Zhu JK; Lu W; Huang L
Atherosclerosis; 2012 Feb; 220(2):343-50. PubMed ID: 22153150
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury.
Maffia P; Grassia G; Di Meglio P; Carnuccio R; Berrino L; Garside P; Ianaro A; Ialenti A
Circulation; 2006 Aug; 114(5):430-7. PubMed ID: 16864728
[TBL] [Abstract][Full Text] [Related]
18. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
[TBL] [Abstract][Full Text] [Related]
19. Increased 12/15-lipoxygenase enhances cell growth, fibronectin deposition, and neointimal formation in response to carotid injury.
Deliri H; Meller N; Kadakkal A; Malhotra R; Brewster J; Doran AC; Pei H; Oldham SN; Skaflen MD; Garmey JC; McNamara CA
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):110-6. PubMed ID: 20947825
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
